Hosted on MSN1mon
Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials
Novavax, Inc. (NVAX) Baird 2024 Global Healthcare Conference (Transcript) Novavax in $123.8M settlement with U.K. agency over COVID vaccine deal Novavax stock plunges as FDA puts clinical hold on ...
Novavax Cashes In On Its COVID Albatross -- Challenges Remain (Rating Upgrade)
With its significant cash infusions from offloading its COVID assets, Novavax had just over $1 billion as it exited Q3, 2024.